← SynDRA
TALIBEGRON
SynDRA canonical compound SYN0025727 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ADRB3 |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRB3 AGONIST
Cross-references
Synonyms
- ZD-2079
- Talibegron [INN]
- UNII-M7O3VK2O7W
- M7O3VK2O7W
- talibegronum
- RefChem:187309
- SCHEMBL328977
- orb2815163
- CHEBI:93123
- T202547
- BRD-K64157027-003-01-9
- BRD-K64157027-003-02-7
- C18H21NO4.HCl
- Tox21_113587
- ZD2079
- Talibegron hydrochloride [USAN]
- CAS-178600-17-4
- Talibegron hydrochloride (USAN)
- UNII-N251Q608VU
- ZD 2079 hydrochloride
- orb1703896
- HY-15378
- ICID2079
- Talibegron HCl
- SCH-417849
- Tox21_113587_1
- TS-08343
- SCHEMBL1230810
- Talibegron hydrochloride
- DSSTox_GSID_49042
- NCGC00092315-01
- AC1L4KMI
- N251Q608VU
- CS-0006037
- DSSTox_RID_83233
- HMS3413I07
- KCEFVYIWOQSJCH-LMOVPXPDSA-N
- DSSTox_CID_28968
Look up TALIBEGRON in the interactive SynDRA portal →